Bavarian Nordic (BAVA.CO) - Interim Financial Report for the Period 1 January to 31 March 2013
5/16/2013 9:56:12 AM
More...
|
Greenphire's ClinCard Technology Platform Selected by Bavarian Nordic (BAVA.CO) for Major Vaccine Trial
3/12/2013 10:27:02 AM
More...
|
Bavarian Nordic (BAVA.CO) Announces Changes in Management
1/22/2013 9:20:24 AM
More...
|
Bavarian Nordic (BAVA.CO) Consolidates its Vaccine Manufacturing in Denmark
1/11/2013 9:38:36 AM
More...
|
Bavarian Nordic (BAVA.CO) Issues Revised Financial Calendar for 2013
12/21/2012 8:51:39 AM
More...
|
Bavarian Nordic (BAVA.CO) - Interim Financial Report for the Period 1 January to 30 September 2012
11/13/2012 8:29:42 AM
More...
|
Bavarian Nordic (BAVA.CO) Reports Preliminary Data From Phase 2 Trial of CV-301 in Metastatic Breast Cancer
10/1/2012 9:57:40 AM
More...
|
U.S. Government Expands Population Eligible to Receive Bavarian Nordic (BAVA.CO)'s Smallpox Vaccine in an Emergency
7/11/2012 9:25:25 AM
More...
|
Bavarian Nordic (BAVA.CO) Awarded Contract From the U.S. Government to Advance the Development of New MVA-BN(R) Based Vaccines
6/18/2012 9:32:54 AM
More...
|
U.S. Government Supports Phase 3 Study of Bavarian Nordic (BAVA.CO)'s Smallpox Vaccine
5/22/2012 11:40:49 AM
More...
|
|